Xenon Pharmaceuticals EPS Basic from Tax Loss Carryforward (Quarterly) Analysis

Xenon Pharmaceuticals, Inc. (XENE)

42.23 -0.85 (-1.97%) USD | NASDAQ | Feb 20, 16:00

42.50 +0.27 (+0.64%) Pre-Market: 09:08

View EPS Basic from Tax Loss Carryforward (Quarterly) for XENE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	--
Edesa Biotech, Inc.	--
Lexaria Bioscience Corp.	--
ProMIS Neurosciences, Inc.	--